Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 91 checked references that resolve
resolves10.1038/bjc.2012.451Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
resolves10.1016/S1470-2045(20)30109-1Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
resolves10.1038/ncomms10001A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
resolves10.1016/j.cell.2018.10.014Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
resolves10.1038/35869HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
resolves10.1038/ng.2806Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
resolves10.1158/1078-0432.CCR-21-1157Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma
resolves10.4049/jimmunol.1002629HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
resolves10.1016/j.ccell.2021.12.006Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
resolves10.1038/s41596-020-0292-xCellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes
resolves10.1016/j.eclinm.2021.100797First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors
resolves10.1002/hep.30493Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma
resolves10.1073/pnas.1100354108HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8
<sup>+</sup>
T lymphocytes
resolves10.1126/science.abf8271Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
resolves10.1073/pnas.1617709114Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
resolves10.1038/s41422-020-00402-8Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
resolves10.1002/hep.31092Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
resolves10.1038/nrc3038Otto Warburg's contributions to current concepts of cancer metabolism
resolves10.1038/nature12213Mutational heterogeneity in cancer and the search for new cancer-associated genes
resolves10.1158/1078-0432.CCR-16-2770Overexpressed Fatty Acid Synthase in Gastrointestinal Stromal Tumors: Targeting a Progression-Associated Metabolic Driver Enhances the Antitumor Effect of Imatinib
resolves10.1093/infdis/jiab403<i>Clonorchis sinensis</i> Reinfection Rate and Reinfection Determinants: A Prospective Cohort Study in Hengxian County, Guangxi, China
resolves10.1158/1078-0432.CCR-18-0078Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention
resolves10.1016/j.cels.2019.03.003DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors
resolves10.1101/gr.107524.110The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
resolves10.1038/ng1180PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
resolves10.1038/nri.2017.49Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
resolves10.1038/ng.2273Exome sequencing of liver fluke–associated cholangiocarcinoma
resolves10.1158/0008-5472.CAN-12-1470Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with
<i>BRCA1/2</i>
Inactivation
resolves10.1172/JCI146186Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling
resolves10.1038/nmeth.4402Reversed graph embedding resolves complex single-cell trajectories
resolves10.1007/s00018-021-03857-zDual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells
resolves10.1186/s12864-016-3404-9ChimPipe: accurate detection of fusion genes and transcription-induced chimeras from RNA-seq data
resolves10.1038/nmeth.2883PyClone: statistical inference of clonal population structure in cancer
resolves10.1038/s41591-018-0078-7Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
resolves10.1093/nar/gkw520FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
resolves10.1073/pnas.0506580102Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
resolves10.3389/fmolb.2019.00106Fatty Acid Synthase Contributes to Restimulation-Induced Cell Death of Human CD4 T Cells
resolves10.1093/nar/gkq603ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
resolves10.1093/annonc/mdz103Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma
resolves10.1038/ncomms5378The Opisthorchis viverrini genome provides insights into life in the bile duct
The 53 references without a DOI — listed, not checked
no DOI — not checkedInfection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis)
no DOI — not checkedref2
no DOI — not checkedref11
no DOI — not checkedref14
no DOI — not checkedGlutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression
no DOI — not checkedref16
no DOI — not checkedBreast cancer: FASN inhibitor increases survival
no DOI — not checkedTranslational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with Durvalumab plus Monalizumab (anti-NKG2A)
no DOI — not checkedref29
no DOI — not checkedSequenza: allele-specific copy number and mutation profiles from tumor sequencing data
no DOI — not checkedGlobal burden of human food-borne trematodiasis: a systematic review and meta-analysis
no DOI — not checkedMacrophage Metabolism As Therapeutic Target for Cancer
no DOI — not checkedref35
no DOI — not checkedref36
no DOI — not checkedAccuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
no DOI — not checkedCOAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
no DOI — not checkedCD103(+) CD8 T Cells in the Toxoplasma-Infected Brain Exhibit a Tissue-Resident
no DOI — not checkedIntegrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response
no DOI — not checkedClonorchis sinensis acetoacetyl-CoA thiolase: identification and characterization of its potential role in surviving in the bile duct
no DOI — not checkedSingle-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
no DOI — not checkedref70
no DOI — not checkedref72
no DOI — not checked0 facilitates sensitive and confident localization of the targets of focal somatic copynumber alteration in human cancers
no DOI — not checkedOsteopontin: A Key Regulator of Tumor Progression and Immunomodulation
no DOI — not checkedSmall is beautiful-a glycolytic metabolite signals mTORC1 activation in cancer cell metabolism
no DOI — not checkedThe global epidemiology of clonorchiasis and its relation with cholangiocarcinoma
no DOI — not checkedMonalizumab in combination with cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): clinical and translational biomarker results
no DOI — not checkedref99
no DOI — not checkedMigrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
no DOI — not checkedref107
no DOI — not checkedWhole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
no DOI — not checkedan upgraded illustrator for the visualization of biological sequences
no DOI — not checkedCsi-let-7a-5p delivered by extracellular vesicles from a liver fluke activates M1-like macrophages and exacerbates biliary injuries
no DOI — not checkedSingle-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
no DOI — not checkedPan-cancer single-cell landscape of tumor-infiltrating T cells
no DOI — not checkedref127
no DOI — not checkedref128
no DOI — not checkedref129
no DOI — not checkedref130
no DOI — not checkedref131
no DOI — not checkedref132
no DOI — not checkedref133
no DOI — not checkedref134
no DOI — not checkedref135
no DOI — not checkedref136
no DOI — not checkedref137
no DOI — not checkedref138
no DOI — not checkedref139
no DOI — not checkedref140
no DOI — not checkedref141
no DOI — not checkedref142
no DOI — not checkedref143
no DOI — not checkedref144
checked 2026-08-27 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.